Viktoria Fana

Medicine & Life Sciences

1. Adalimumab 26%
2. Antibodies 11%
3. Antirheumatic Agents 56%
4. Arthritis 15%
5. Atlases 26%
6. Betamethasone 9%
7. Biopsy 11%
8. C-Reactive Protein 6%
9. Chronic Disease 6%
10. Cohort Studies 15%
11. Color 6%
12. Cross-Sectional Studies 14%
13. Denmark 31%
14. Differential Diagnosis 8%
15. Doppler Ultrasonography 21%
16. Double-Blind Method 20%
17. Foot 17%
18. Glucocorticoids 19%
19. Gout 100%
20. Hand 15%
21. Health Care Outcome Assessment 14%
22. Immunity 17%
23. Inflammation 12%
24. Inflammatory Bowel Diseases 19%
25. Infliximab 24%
26. Injections 18%
27. Intramuscular Injections 7%
28. Joints 51%
29. Lacrimal Apparatus 25%
30. Logistic Models 5%
31. Lyme Disease 18%
32. Microbiota 20%
33. Odds Ratio 8%
34. Osteitis 9%
35. Parotid Gland 6%
36. Post-Lyme Disease Syndrome 6%
37. Rheumatoid Arthritis 86%
38. Rheumatologists 10%
39. Rheumatology 31%
40. Salivary Glands 64%
41. Submandibular Gland 7%
42. Synovitis 59%
43. Tendons 21%
44. Tenosynovitis 28%
45. Therapeutics 5%
46. Tick-Borne Diseases 29%
47. Tumor Necrosis Factor Inhibitors 25%
48. Ultrasonography 20%
49. University Hospitals 6%
50. Uric Acid 21%